Multi-modal analysis of psychiatric and dementia outcomes
- PI
- Pathak, Gita
- DAR ID
- 10947
- Initial Approval Date
- August 12, 2025
- Current DAR Status
- Active
- PI Institution
- Icahn School of Medicine at Mount Sinai
- PI Institution Country
- United States
- PI Institution Type
- Non-Profit
Requested Datasets (26)
NG00067Alzheimer's Disease Sequencing Project Umbrella StudyNG00106LASI-DAD Genotyping Chip Data (Illumina Infinium GSA-24 v2.0), Imputed Data (1000 Genomes Phase 3 v5 and TOPMed r2)NG00114DNA Methylation in Alzheimer disease brainsNG00119Health and Retirement Study Genotype Data 2006-2012NG00117NCRAD Families GWASNG00127A longitudinal study of Alzheimer's Disease and other dementing illnesses – KnightADRC GWASNG00132Health and Retirement Study (HRS) APOE and Serotonin Transporter AllelesNG00102Genomic atlas of the proteome from brain, CSF and plasma prioritizes proteins implicated in neurological disordersNG00153Health and Retirement Study (HRS) DNA MethylationNG00022ADC1 - Alzheimer's Disease Center Dataset 1NG00023ADC2 - Alzheimer's Disease Center Dataset 2NG00024ADC3 - Alzheimer's Disease Center Dataset 3
Show more
NG00068ADC4 - Alzheimer's Disease Center Dataset 4NG00069ADC5 - Alzheimer's Disease Center Dataset 5NG00070ADC6 - Alzheimer's Disease Center Dataset 6NG00071ADC7 - Alzheimer's Disease Center Dataset 7NG00136ADC8 - Alzheimer's Disease Center Dataset 8NG00137ADC9 - Alzheimer's Disease Center Dataset 9NG00138ADC10 - Alzheimer's Disease Center Dataset 10NG00139ADC11 - Alzheimer's Disease Center Dataset 11NG00140ADC12 - Alzheimer's Disease Center Dataset 12NG00149ADC13 - Alzheimer's Disease Center Dataset 13NG00150ADC14 - Alzheimer's Disease Center Dataset 14NG00151ADC15 - Alzheimer's Disease Center Dataset 15NG00100Novel Alzheimer Disease Risk Loci and Pathways in African American Individuals Using the African Genome Resources Panel: A Meta-analysis. Kunkle et al. (2021)NG00035GWAS of CSF tau levels identifies risk variants for Alzheimer’s Disease
Research Use Statement
a. Objectives of the Proposed Research
This study aims to investigate the relationship between psychiatric traits and age-related cognitive decline, addressing a critical knowledge gap in understanding how mental health influences aging outcomes.
b. Study Design
The study employs a multi-level investigative approach combining epidemiological, genetic, and molecular methodologies. The design incorporates three complementary components: first, identification of phenotypic associations between psychiatric traits and MCI/AD through comprehensive clinical assessment; second, investigation of genetic architecture through analysis of coding and non-coding variants, genetic correlation assessments, polygenic scoring, and Mendelian randomization for causal inference; and third, examination of molecular mechanisms through genetically regulated epigenetic and proteomic processes. The study design enables stratified analyses by sex and ethnicity while controlling for demographic and lifestyle confounders, providing a comprehensive framework for understanding the psychiatric-cognitive decline relationship across multiple biological levels.
c. Analytical Plan
The analytical approach will proceed in sequential phases, beginning with statistical modeling to identify psychiatric traits significantly associated with MCI and AD outcomes while adjusting for demographic and lifestyle factors. Genetic analyses will employ polygenic risk scores and Mendelian randomization techniques to establish causal relationships between psychiatric conditions (particularly depression and alcohol use disorder) and cognitive outcomes. Molecular analyses will focus on identifying shared genetic loci between psychiatric and cognitive phenotypes, followed by investigation of genetically regulated methylation and proteomic markers as potential mediators. The analysis plan includes development of molecular weights to aid causal inference analyses and determination of effect directionality, with stratified results reported by sex and ethnicity to identify population-specific risk patterns and potential intervention targets.
This study aims to investigate the relationship between psychiatric traits and age-related cognitive decline, addressing a critical knowledge gap in understanding how mental health influences aging outcomes.
b. Study Design
The study employs a multi-level investigative approach combining epidemiological, genetic, and molecular methodologies. The design incorporates three complementary components: first, identification of phenotypic associations between psychiatric traits and MCI/AD through comprehensive clinical assessment; second, investigation of genetic architecture through analysis of coding and non-coding variants, genetic correlation assessments, polygenic scoring, and Mendelian randomization for causal inference; and third, examination of molecular mechanisms through genetically regulated epigenetic and proteomic processes. The study design enables stratified analyses by sex and ethnicity while controlling for demographic and lifestyle confounders, providing a comprehensive framework for understanding the psychiatric-cognitive decline relationship across multiple biological levels.
c. Analytical Plan
The analytical approach will proceed in sequential phases, beginning with statistical modeling to identify psychiatric traits significantly associated with MCI and AD outcomes while adjusting for demographic and lifestyle factors. Genetic analyses will employ polygenic risk scores and Mendelian randomization techniques to establish causal relationships between psychiatric conditions (particularly depression and alcohol use disorder) and cognitive outcomes. Molecular analyses will focus on identifying shared genetic loci between psychiatric and cognitive phenotypes, followed by investigation of genetically regulated methylation and proteomic markers as potential mediators. The analysis plan includes development of molecular weights to aid causal inference analyses and determination of effect directionality, with stratified results reported by sex and ethnicity to identify population-specific risk patterns and potential intervention targets.
Non-Technical Summary
This research examines how mental health conditions like depression and anxiety may increase the risk of memory problems and Alzheimer's disease as people age. Using genetic data and biological markers, we'll study whether psychiatric conditions directly cause cognitive decline or if they share common underlying causes. The study will identify which mental health factors pose the greatest risk for dementia, particularly looking at differences between men and women and various ethnic groups. Results could help better predict and prevent cognitive decline by addressing mental health early in life, potentially improving outcomes for millions facing both psychiatric and age-related brain conditions.
Reported Publications
Publications shown are those reported by investigators through NIAGADS DAR reporting and renewal processes and may not represent a complete list of publications associated with the project.
No publications have been reported for this DAR.